At $10.4 billion dollars, biotech giant Amgen's acquisition of Onyx is the fifth-largest biotech deal in history - and definitely won't be the last. This deal is a perfect illustration of why there’s so much money being made in biotech...
Investing in new companies in 2013
- Amgen (Nasdaq: AMGN) Deal Shows How to Find Biotech's Best Investments
- Unlocked: The Fastest-Growing Companies in America
IPOs are back, big time. Even unsexy companies are sprouting sweet IPO gains.
Take organic grocer Sprouts Farmers Market. It gained nearly 123% in its first day of trading Thursday - the best initial public offering debut since LinkedIn more than two years ago.
IPOs as diverse as Norwegian Cruise Line Holdings Ltd. and fast-casual dining chain Noodles & Co. have soared... The market has locked and loaded on about $4 billion in U.S. IPOs so far this year.
At that pace, companies "going public" would raise the most this year since at least 1999.
Welcome to the white-hot IPO market.
There's only one problem...
If you're not rich - you know, aren't one of those high-net-worth "accredited investors" (in essence, an insider or someone with a good buddy at an investment bank) - then you probably are watching from the sidelines. And that's why I can't wait to show this to you today, because you don't have to watch the Millionaire's Game anymore. You can finally play it.
Pick up some of these shares today, and you can win it, too. Big...